Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Business

Target says shoppers are buying fewer groceries and home goods

by admin May 23, 2024
May 23, 2024
Target says shoppers are buying fewer groceries and home goods

Target said Wednesday that its customers reduced spending on groceries and home goods as concern about high prices persisted last quarter.

The retailer said in its latest earnings report that overall customer traffic fell 1.9%, while the average amount that customers spent on those visits also dropped 1.9%. The company’s stock declined Wednesday morning as its profit missed Wall Street’s expectations for the first time since November 2022.

The Target earnings come amid broader concerns that U.S. consumers may be getting more discerning with their money, as savings dwindle, debt grows and prices remain high. Some CEOs of major consumer brands have warned about spending declines, though others, like executives at Sweetgreen and Delta Air Lines, have still seen growth.

On a call with reporters, CEO Brian Cornell said the company’s results reflect “continued soft trends in discretionary categories.’

He said the company wants to make sure it offers customers value and communicates that in a clear way. Target sought to get ahead of Wednesday’s report by announcing earlier this week that it would be cutting prices on thousands of items throughout its stores, including groceries and other staples.

Target remains more associated with discretionary purchases than with groceries: It only gets about 20% of its sales from food compared with rival Walmart, which draws about 60%.

As a result, it is more affected by any pullback in spending.

And even though inflation has recently shown signs of further slowing, the official 12-month rate remains above 3%, above the Federal Reserve’s 2% target.

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Home sales slipped unexpectedly in April despite big gains in supply
next post
Hims & Hers Health says it will offer compounded GLP-1 injections

You may also like

On the sidelines of a pricier Kentucky Derby,...

May 5, 2024

Donald Trump set to receive $1.25 billion worth...

April 23, 2024

Trump says it’s ‘highly unlikely’ he will fire...

July 18, 2025

Chevy Bolt owners to receive settlement checks after...

May 20, 2024

U.S. unemployment rate ticks up to 4.3% amid...

August 5, 2024

Things are getting better at Boeing under CEO...

July 29, 2025

Best Buy launches third-party marketplace as it looks...

August 20, 2025

Lawmakers ask Mark Zuckerberg to show how Facebook,...

August 17, 2024

Drone company’s stock soars after appointing Donald Trump...

November 28, 2024

Ford delays new EV plant and cancels electric...

August 23, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s...

    • 2

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    • 3

      Tartana Drilling to Verify Upgrading of 45,000 Tonne Copper Resource

    • 4

      China executes man who plowed car into crowds in deadliest attack in a decade

    • 5

      Trump has assembled a team of China hawks. How will Beijing respond?

    Categories

    • Business (1,289)
    • Investing (3,377)
    • Science (605)
    • World (3,677)
    Footer Logo

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 dailywashingtoninsider.com | All Rights Reserved